4/A//SEC Filing
Khosrovi Behzad 4/A
Accession 0001140361-10-046210
CIK 0001389545other
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 2:11 PM ET
Size
6.2 KB
Accession
0001140361-10-046210
Insider Transaction Report
Form 4/AAmended
Khosrovi Behzad
VP Research and Development
Transactions
- Award
Option (right to buy)
2010-11-15+40,000→ 364,200 totalExercise: $1.89From: 2011-11-15Exp: 2020-11-14→ Common Stock (40,000 underlying)
Footnotes (2)
- [F1]Original Form 4 filed on November 15, 2010. This amendment is filed to correct the exercise price from $1.85 to $1.89 per share.
- [F2]Original Form 4 filed on November 15, 2010. This amendment is filed to correct the grant date from November 12, 2010 to November 15, 2010, the date the last signature to the Board Written Consent granting the options was received by the Company.
Documents
Issuer
NovaBay Pharmaceuticals, Inc.
CIK 0001389545
Entity typeother
Related Parties
1- filerCIK 0001410078
Filing Metadata
- Form type
- 4/A
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 2:11 PM ET
- Size
- 6.2 KB